Xiao-Yi Kuai1, Ze-Yu Ji, Hong-Jie Zhang. 1. Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China.
Abstract
AIM: To detect the expression of mitochondrial uncoupling protein 2 (UCP2) in colon cancer and analyze the relation between UCP2 expression and clinical pathological features of colon cancer. METHODS: Fifteen colon tissue samples and 15 its adjacent tissue samples were obtained from colon cancer patients during surgical interventions. UCP2 expression was detected with immunohistochemical method in 10 normal controls, 10 hyperplastic polyp patients, 20 tubular adenoma patients and 78 colon cancer patients. Patients with rectal cancer were excluded. Quantitative reverse transcription polymerase chain reaction and Western blotting were used to detect UCP2 expressions in colon cancer tissue samples and its adjacent tissue samples. Relation between UCP2 expression and clinical pathological features of colon cancer was also analyzed. RESULTS: The UCP2 mRNA expression level was four-fold higher in colon cancer tissue samples than in its adjacent tissue samples. The UCP2 protein expression level was three-fold higher in colon cancer tissue samples than in its adjacent normal tissue samples. The UCP2 was mainly expressed in cytoplasm. The UCP2 was not expressed in normal colon mucosa. Strong positive staining for UCP2 with a diffuse distribution pattern was identified throughout the mucosa in colon cancer tissue samples with a positive expression rate of 85.9%. The UCP2 expression level was higher in colon cancer tissue samples at clinical stages III and IV than in those at stage I + II. Univariate analysis showed that the high UCP2 expression level was significantly correlated to colon cancer metastasis (hazard ratio = 4.321, confidence interval = 0.035-0.682, P = 0.046). CONCLUSION: UCP2 is highly expressed in human colon cancer tissue and may be involved in colon cancer metastasis.
AIM: To detect the expression of mitochondrial uncoupling protein 2 (UCP2) in colon cancer and analyze the relation between UCP2 expression and clinical pathological features of colon cancer. METHODS: Fifteen colon tissue samples and 15 its adjacent tissue samples were obtained from colon cancerpatients during surgical interventions. UCP2 expression was detected with immunohistochemical method in 10 normal controls, 10 hyperplastic polyppatients, 20 tubular adenomapatients and 78 colon cancerpatients. Patients with rectal cancer were excluded. Quantitative reverse transcription polymerase chain reaction and Western blotting were used to detect UCP2 expressions in colon cancer tissue samples and its adjacent tissue samples. Relation between UCP2 expression and clinical pathological features of colon cancer was also analyzed. RESULTS: The UCP2 mRNA expression level was four-fold higher in colon cancer tissue samples than in its adjacent tissue samples. The UCP2 protein expression level was three-fold higher in colon cancer tissue samples than in its adjacent normal tissue samples. The UCP2 was mainly expressed in cytoplasm. The UCP2 was not expressed in normal colon mucosa. Strong positive staining for UCP2 with a diffuse distribution pattern was identified throughout the mucosa in colon cancer tissue samples with a positive expression rate of 85.9%. The UCP2 expression level was higher in colon cancer tissue samples at clinical stages III and IV than in those at stage I + II. Univariate analysis showed that the high UCP2 expression level was significantly correlated to colon cancer metastasis (hazard ratio = 4.321, confidence interval = 0.035-0.682, P = 0.046). CONCLUSION:UCP2 is highly expressed in humancolon cancer tissue and may be involved in colon cancer metastasis.
Authors: D W Voehringer; D L Hirschberg; J Xiao; Q Lu; M Roederer; C B Lock; L A Herzenberg; L Steinman; L A Herzenberg Journal: Proc Natl Acad Sci U S A Date: 2000-03-14 Impact factor: 11.205
Authors: José M Cuezva; Maryla Krajewska; Miguel López de Heredia; Stanislaw Krajewski; Gema Santamaría; Hoguen Kim; Juan M Zapata; Hiroyuki Marusawa; Margarita Chamorro; John C Reed Journal: Cancer Res Date: 2002-11-15 Impact factor: 12.701
Authors: Mary-Ellen Harper; Andreas Antoniou; Elizabeth Villalobos-Menuey; Alicia Russo; Richard Trauger; Minda Vendemelio; Amanda George; Richard Bartholomew; Dennis Carlo; Azhar Shaikh; Jami Kupperman; Evan W Newell; Ivan A Bespalov; Susan S Wallace; Ye Liu; Jeffrey R Rogers; Gregory L Gibbs; Jack L Leahy; Robert E Camley; Robert Melamede; M Karen Newell Journal: FASEB J Date: 2002-10 Impact factor: 5.191
Authors: Masayoshi Horimoto; Murray B Resnick; Tamako A Konkin; Justin Routhier; Jack R Wands; György Baffy Journal: Clin Cancer Res Date: 2004-09-15 Impact factor: 12.531
Authors: Gustav Mattiasson; Mehrdad Shamloo; Gunilla Gido; Kavitha Mathi; Gregor Tomasevic; Saili Yi; Craig H Warden; Roger F Castilho; Thorsten Melcher; Mirella Gonzalez-Zulueta; Karoly Nikolich; Tadeusz Wieloch Journal: Nat Med Date: 2003-07-13 Impact factor: 53.440
Authors: Martin D Brand; Charles Affourtit; Telma C Esteves; Katherine Green; Adrian J Lambert; Satomi Miwa; Julian L Pakay; Nadeene Parker Journal: Free Radic Biol Med Date: 2004-09-15 Impact factor: 7.376
Authors: Stephan M Huber; Lena Butz; Benjamin Stegen; Dominik Klumpp; Norbert Braun; Peter Ruth; Franziska Eckert Journal: Front Physiol Date: 2013-08-14 Impact factor: 4.566